Clinical Trial Update: Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With Type 2 Diabetes Mellitus

View source ↗

Summary

Registry study update assessing the effectiveness and safety of weight loss with Enavogliflozin in patients with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Enavogliflozin (enavogliflozin)

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: Type 2 Diabetes Mellitus | Status: ACTIVE_NOT_RECRUITING